Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors von Sella, Tal, Zheng, Yue, Tan‐Wasielewski, Zhenying, Rosenberg, Shoshana M., Poorvu, Philip D., Tayob, Nabihah, Ruddy, Kathryn J., Gelber, Shari I., Tamimi, Rulla M., Schapira, Lidia, Come, Steven E., Peppercorn, Jeffrey M., Borges, Virginia F., Partridge, Ann H., Ligibel, Jennifer A.

Volltext

Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center von Losk, Katya, Freedman, Rachel A., Laws, Alison, Kantor, Olga, Mittendorf, Elizabeth A., Tan-Wasielewski, Zhenying, Trippa, Lorenzo, Lin, Nancy U., Winer, Eric P., King, Tari A.

Volltext

Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial von Goel, Shom, Pernas, Sonia, Tan-Wasielewski, Zhenying, Barry, William T., Bardia, Aditya, Rees, Rebecca, Andrews, Chelsea, Tahara, Rie Kawabori, Trippa, Lorenzo, Mayer, Erica L., Winer, Eric P., Spring, Laura M., Tolaney, Sara M.

Volltext

Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal... von Lee, Elizabeth K., Tan-Wasielewski, Zhenying, Aghajanian, Carol, Coleman, Robert L., Curtis, Jennifer, Hirsch, Michelle S., Matulonis, Ursula A., Cantley, Lewis C., Mills, Gordon B., Doyle, L. Austin, Liu, Joyce F.

Volltext

Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer von Lee, Elizabeth K., Tan-Wasielewski, Zhenying, Matulonis, Ursula A., Birrer, Michael J., Wright, Alexi A., Horowitz, Neil, Konstantinopoulos, Panagiotis A., Curtis, Jennifer, Liu, Joyce F.

Volltext

Oncotype DX testing in early-stage node-positive breast cancer and impact on chemotherapy use at a comprehensive cancer center von Losk, Katya, Freedman, Rachel A., Mittendorf, Elizabeth A., Tan-Wasielewski, Zhenying, Trippa, Lorenzo, King, Tari A.

Volltext

A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer von Barroso-Sousa, Romualdo, Krop, Ian E., Trippa, Lorenzo, Tan-Wasielewski, Zhenying, Li, Tianyu, Osmani, Wafa, Andrews, Chelsea, Dillon, Deborah, Richardson, Edward T., Pastorello, Ricardo G., Winer, Eric P., Mittendorf, Elizabeth A., Bellon, Jennifer R., Schoenfeld, Jonathan D., Tolaney, Sara M.

Volltext

A phase II study of pembrolizumab in combination with palliative radiotherapy (RT) for hormone receptor-positive (HR+) metastatic breast cancer (MBC) von Barroso-Sousa, Romualdo, Krop, Ian E., Trippa, Lorenzo, Tan-Wasielewski, Zhenying, Li, Tianyu, Osmani, Wafa, Andrews, Chelsea, Dillon, Deborah, Richardson, Edward T., Winer, Eric P., Mittendorf, Elizabeth A., Schoenfeld, Jonathan Daniel, Tolaney, Sara M.

Volltext

Body weight changes in young breast cancer survivors and associated predictors von Sella, Tal, Tan-Wasielewski, Zhenying, Rosenberg, Shoshana M., Poorvu, Philip Daniel, Ruddy, Kathryn Jean, Gelber, Shari I., Tamimi, Rulla M., Schapira, Lidia, Come, Steven E., Peppercorn, Jeffrey M., Borges, Virginia F., Partridge, Ann H., Ligibel, Jennifer A.

Volltext

Abstract P3-10-08: A phase II study of cisplatin and the Wee1 inhibitor adavosertib in metastatic triple-negative breast cancer (mTNBC) von Keenan, Tanya E., Tan-Wasielewski, Zhenying, Trippa, Lorenzo, Kochupurakkal, Bose, Guerriero, Jennifer L., Tahara, Rie K., Winship, Grace, Osmani, Wafa, Andrews, Chelsea, Conway, Jake R., He, Meng X, Pastorello, Ricardo, Tracy, Adam, Godin, Robert E., Overmoyer, Beth A., Winer, Eric P., Mittendorf, Elizabeth A., Shapiro, Geoffrey I, Van Allen, Eliezer M, Tolaney, Sara M

Volltext

TBCRC 030: A randomized phase II study of preoperative cisplatin versus paclitaxel in TNBC—Evaluating the homologous recombination deficiency (HRD) biomarker von Mayer, Erica L., Abramson, Vandana Gupta, Jankowitz, Rachel Catherine, Falkson, Carla Isadora, Marcom, Paul Kelly, Traina, Tiffany A., Carey, Lisa A., Rimawi, Mothaffar F., Specht, Jennifer M., Miller, Kathy, Stearns, Vered, Perou, Charles M., Richardson, Andrea L., Tung, Nadine M., Barry, William Thomas, Tan-Wasielewski, Zhenying, Timms, Kirsten, Hartman, Anne-Renee, Wolff, Antonio C., Winer, Eric P.

Volltext

Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer von Lee, Elizabeth K, Tan-Wasielewski, Zhenying, Matulonis, Ursula A, Birrer, Michael J, Wright, Alexi A, Horowitz, Neil, Konstantinopoulos, Panagiotis A, Curtis, Jennifer, Liu, Joyce F

Volltext

Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal... von Lee, Elizabeth K, Tan-Wasielewski, Zhenying, Aghajanian, Carol, Coleman, Robert L, Curtis, Jennifer, Hirsch, Michelle S, Matulonis, Ursula A, Cantley, Lewis C, Mills, Gordon B, Doyle, L Austin, Liu, Joyce F

Volltext